Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Company
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03 2022-12-09 pm EST
51.72 USD   -0.12%
05:00pWeekly market update : Waiting for Jay
MS
02:10pU.S. CDC expands use of bivalent COVID vaccines for kids as young as 6 months
RE
01:55pPfizer-BioNTech COVID-19, Influenza Combo Vaccine Gets FDA Fast Track Designation
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Pfizer, Inc.
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- vaccines (52.4%);

- drugs for the treatment of cancer (15.2%);

- cardiovascular, metabolic and analgesic drugs (11.5%);

- injectable, anti-infectives drugs and active pharmaceutical ingredients (9%);

- drugs for inflammatory and immune diseases (5.5%);

- drugs for rare diseases (4.4%);

- other (2%).

At the end of 2021, the group had more than 39 production sites worldwide.

Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).

Number of employees : 79 000 people.
Sales per Business
2021
Biopharma79 557.0097.9%
Other Business Activities1 731.002.1%
USD in Million
Sales per region
20202021Delta
United States21 712.0051.8%29 746.0036.6% +37%
Emerging Markets5 857.5214%20 701.0025.5% +253.41%
Developed Europe7 788.0018.6%18 336.0022.6% +135.44%
Japan2 514.486%7 315.929% +190.95%
Developed Rest of World1 521.523.6%5 190.086.4% +241.11%
USD in Million
Managers
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
David Denton Chief Financial Officer & Executive Vice President 56 2022
Mikael Dolsten Executive VP, President-Research & Development 63 2010
Lidia Fonseca Executive VP, Chief Digital & Technology Officer 52 -
Aida Habtezion Chief Medical Officer - -
Annaliesa Anderson, Dr. VP, CSO-Bacterial Research & Hospital - -
Rady Johnson Executive VP, Chief Compliance & Risk Officer 60 2013
Bryan Dunn Investor Relations Contact - -
Christopher J. Stevo Senior Vice President - 2021
Margaret M. Madden Secretary, Chief Governance Counsel & Senior VP - -
Members of the board
Name Title Age Since
Albert Bourla Chairman, Chief Executive & Operating Officer 59 2020
Suzanne Johnson Independent Director 64 2007
Helen H. Hobbs, Dr. Independent Director 68 2011
Shantanu Narayen Lead Independent Director 57 -
James Smith Independent Director 61 2014
Joseph Echevarria Independent Director 64 2015
Ronald E. Blaylock Independent Director 61 2017
Dan R. Littman, Dr. Independent Director 68 2018
James R. Quincey Independent Director 56 2020
Susan J. Hockfield, Dr. Independent Director 70 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,516,314,537 5,610,756,746 59.0% 3,903,000,000 41.0% 59.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 470,112,034 8.38%
SSgA Funds Management, Inc. 287,612,741 5.12%
Capital Research & Management Co. (World Investors) 248,850,529 4.43%
Wellington Management Co. LLP 210,874,152 3.76%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 121,369,861 2.16%
Geode Capital Management LLC 110,442,140 1.97%
Charles Schwab Investment Management, Inc. 70,123,906 1.25%
Northern Trust Investments, Inc.(Investment Management) 66,587,775 1.19%
Norges Bank Investment Management 56,763,604 1.01%
Holdings
NameEquities%Valuation
PFIZER LIMITED (500680) 29,243,042 63.9% 1,547,158,406 USD
AKERO THERAPEUTICS, INC. (AKRO) 2,525,252 5.44% 106,717,150 USD
VALNEVA SE (VLA) 9,549,761 6.90% 64,615,975 USD
SPRINGWORKS THERAPEUTICS, INC. (SWTX) 2,340,330 3.75% 56,191,323 USD
SOSEI GROUP CORPORATION (4565) 1,885,136 2.30% 25,784,513 USD
BIOATLA, INC. (BCAB) 1,372,052 3.78% 9,453,438 USD
WAVE LIFE SCIENCES LTD. (WVE) 1,875,000 2.16% 8,981,250 USD
NEXTCURE, INC. (NXTC) 1,970,759 7.10% 4,926,898 USD
SPERO THERAPEUTICS, INC. (SPRO) 2,362,348 6.74% 4,630,202 USD
4D MOLECULAR THERAPEUTICS, INC. (FDMT) 341,658 1.06% 2,958,758 USD
Markets and indexes
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  PFIZ11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Pfizer, Inc.
235 Street East 42nd
NY 10017 New York City, New York

Phone : +1 212 573 2323
Fax :
web site : https://investors.pfizer.com/Investors
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pfizer, Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER, INC.-14.92%290 657
JOHNSON & JOHNSON3.57%463 286
ELI LILLY AND COMPANY34.66%353 267
ABBVIE INC.22.59%293 450
NOVO NORDISK A/S22.08%287 434
MERCK & CO., INC.44.64%281 049
ROCHE HOLDING AG-20.09%267 313
ASTRAZENECA PLC30.40%214 308
NOVARTIS AG6.25%196 152
BRISTOL-MYERS SQUIBB COMPANY28.20%177 305
AMGEN INC.27.02%152 374
SANOFI0.47%117 709
GILEAD SCIENCES, INC.20.91%112 217
GSK PLC-9.73%73 637
DAIICHI SANKYO CO., LTD.50.97%61 981
BAYER AG12.19%54 633
TAKEDA PHARMACEUTICAL COMPANY LIMITED28.12%45 745
CHUGAI PHARMACEUTICAL CO., LTD-3.43%43 443
JIANGSU HENGRUI MEDICINE CO., LTD.-23.45%35 592
ASTELLAS PHARMA INC.13.61%28 357
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-37.55%23 286